Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer

被引：5
|
作者：
Hill, Addie [1 ]
Gong, Jun [1 ]
Wilczynski, Sharon [1 ]
Mirza, Rizvan [1 ]
Erhunmwunsee, Loretta [1 ]
Salgia, Ravi [1 ]
机构：
[1] City Hope Canc Ctr, Duarte, CA USA
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2018年 / 14卷 / 09期
关键词：
D O I：
10.1200/JOP.18.00127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：569 / +
页数：5
相关论文
共 50 条
  • [1] NEOADJUVANT CHEMOTHERAPY IN STAGE IIIA NON-SMALL-CELL LUNG-CANCER
    MILROY, R
    MACBETH, F
    THORAX, 1995, 50 : S25 - S30
  • [2] Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer
    Kappers, Ingrid
    Klomp, Houke M.
    Burgers, Jacobus A.
    Van Zandwijk, Nico
    Haas, Rick L. M.
    van Pel, Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) : 4205 - 4207
  • [3] Neoadjuvant multimodal treatment of stage IIIA non-small-cell lung cancer
    Thomas, M
    Rube, C
    Semik, M
    Junker, K
    vonEiff, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (33) : 993 - 998
  • [4] Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy
    Yang, Zhang-Ru
    Liu, Mi-Na
    Yu, Jia-Hua
    Yang, Yun-Hai
    Chen, Tian-Xiang
    Han, Yu-Chen
    Zhu, Lei
    Zhao, Ji-Kai
    Fu, Xiao-Long
    Cai, Xu-Wei
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2059 - 2073
  • [5] Pathologic Response to Neoadjuvant PD-1 Inhibitors and Chemotherapy in Squamous Non-Small-Cell Lung Cancer
    Shi, L.
    Liu, Z.
    Meng, Q.
    Tong, L.
    Li, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S979 - S979
  • [6] Pathologic Complete Responses After Chemotherapy Plus Figitumumab in Stage IV Non-Small-Cell Lung Cancer
    Corral, Jesus
    Lopez-Villalobos, Jose L.
    Gomez-Izquierdo, Lourdes
    Borrego, Isabel
    Paz-Ares, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : E163 - E165
  • [7] Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
    Zhao, Guangyin
    Zhang, Hongyu
    Xu, Fengkai
    Lu, Chunlai
    Zhu, Qiaoliang
    Grossi, Francesco
    Divisi, Duilio
    Ma, Teng
    Gu, Jie
    Ge, Di
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (01) : 141 - 149
  • [8] Management of non-small-cell lung cancer (stage IIIa)
    Gridelli, C
    Rossi, A
    Guerriero, C
    Ferrara, C
    Del Gaizo, F
    Colantuoni, G
    Salerno, V
    Nicolella, D
    TUMORI JOURNAL, 2003, : S103 - S105
  • [9] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03) : 949 - 958
  • [10] Case Report: Pathologic Complete Response to Pembrolizumab in Combination With Neoadjuvant Chemotherapy in a Patient With Stage IIB Squamous Lung Cancer
    Zhang, Lin
    Mai, Wuqian
    Jiang, Wenyang
    Geng, Qing
    FRONTIERS IN SURGERY, 2020, 7
12345